Synapse Open Synapse
Biology

STAT+: Bladder cancer immunotherapy from CG Oncology reduced risk of tumor recurrence

STAT News · · 1 min read

CG Oncology's bladder cancer immunotherapy reduced risk of tumor recurrence by 68% — results that may change how physicians treat certain patients.

Latest from STAT News